Are you Dr. Dranoff?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 55 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
44 Binney St
Boston, MA 02115Phone+1 617-632-5051Fax+1 617-632-5167- Is this information wrong?
Summary
- Dr. Glenn Dranoff, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Dana-Farber Cancer Institute and is a Professor of Medicine at Dana-Farber Cancer Institute.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1988 - 1991
Massachusetts General HospitalInternship, Internal Medicine, 1985 - 1986
Duke University School of MedicineClass of 1985
Certifications & Licensure
MA State Medical License 1988 - 2025
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2004
Publications & Presentations
PubMed
- 1 citationsGranulocyte-Macrophage Colony-Stimulating Factor Influence on Soluble and Membrane-Bound ICOS in Combination with Immune Checkpoint Blockade.Xiaoyu Li, Jingjing Li, Yue Zheng, Sandra J Lee, Jun Zhou, Anita Giobbie-Hurder, Lisa H Butterfield, Glenn Dranoff, F Stephen Hodi> ;Cancer Immunology Research. 2023 Aug 3
- 2 citationsTargeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses.Rohan Diwanji, Neil A O'Brien, Jiyoung E Choi, Beverly Nguyen, Tyler Laszewski, Angelo L Grauel, Zheng Yan, Xin Xu, Jincheng Wu, David A Ruddy, Michelle Piquet, Marc R...> ;Cancer Immunology Research. 2023 Jun 2
- 22 citationsDiscovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy.Simone Bonazzi, Eva d'Hennezel, Rohan E J Beckwith, Lei Xu, Aleem Fazal, Anna Magracheva, Radha Ramesh, Artiom Cernijenko, Brandon Antonakos, Hyo-Eun C Bhang, Roxana G...> ;Cell Chemical Biology. 2023 Mar 16
- Join now to see all
Press Mentions
Atavistik Bio Announces $60 Million Series a Financing to Advance Genetically-Validated Targets in Metabolic Diseases and CancerAugust 24th, 2021- Wugen Appoints New Vice President and Head of NK Research as the Company Continues to Expand Its PipelineNovember 19th, 2020
Cancer Research Institute Names New Stars of Cancer Immunotherapy ResearchJune 21st, 2019- Join now to see all
Hospital Affiliations
Dana-Farber Cancer InstituteBoston, Massachusetts
